<DOC>
	<DOCNO>NCT02126969</DOCNO>
	<brief_summary>The primary hypothesis study hyper-radiosensitivity ( HRS ) see extremely low dos radiation exploit enhance effect chemotherapy , effect differs cellular effect high , standard fraction radiation use traditional radiation treatment paradigm .</brief_summary>
	<brief_title>A Study Chemo +/- Low-dose Radiation Induction Therapy SCCHN</brief_title>
	<detailed_description />
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Histologically cytologically confirm locally advanced head neck cancer squamous type stage III , IVA IV B select Stage II tumor BOT appropriate potentially curative therapy chemoradiotherapy . Measurable disease . ECOG performance status 0 , 1 2 No prior chemotherapy current locally advanced SCCHN . Age ≥18 year . Life expectancy great 3 month Normal organ marrow function measure within 14 day registration define : absolute neutrophil count ≥ 1,000/mcL platelet ≥ 100,000/mcL total bilirubin &lt; institutional upper limit normal AST ( SGOT ≤ 2.5 × institutional upper limit normal Alkaline phosphatase ≤ 2.5 × institutional upper limit normal creatinine within normal institutional limit OR Creatinine clearance ≥ 60 mL/min/1.73 m2 patient creatinine level institutional normal . Women childbearing potential men must agree use adequate contraception ( hormonal barrier method birth control ; abstinence ) prior study entry , throughout duration active treatment 4 month completion chemotherapy radiation . Men treat enrol protocol must also agree use adequate contraception prior study , duration active study treatment , 4 month completion chemotherapy radiation ( induction definitive ) administration . Ability understand willingness sign write informed consent document . Prior chemotherapy SCCHN Patients receive investigational agent . Patients know brain metastasis History allergic reaction attribute compound similar chemical biologic composition Carboplatin Docetaxel . Uncontrolled intercurrent illness include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , psychiatric illness/social situation would limit compliance study requirement . Pregnant woman HIVpositive patient combination antiretroviral therapy Other prior malignancy except adequately treat basal cell squamous cell skin cancer , situ cervical cancer , adequately treat previous Stage I II cancer patient currently complete remission cancer patient diseasefree 3 year . Patients nasopharynx salivary gland primary site Patients distant metastatic disease ( M1c ) Patients grade II great peripheral neuropathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Cancer</keyword>
	<keyword>Low dose radiation</keyword>
</DOC>